Wednesday, February 4, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Peoples Bancorp Stock Rating and Price Targets Update

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
Finances (2)
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Analyst Alexander Twerdahl of Piper Sandler has upgraded Peoples Bancorp (NASDAQ: PEBO) to an Overweight rating, setting a Price Target of $34.

The average one-year price target for Peoples Bancorp Inc. currently stands at $35.292, with various forecasts ranging between $30.3 and $42.

In a previous update, Piper Sandler had raised Peoples Bancorp’s Price Target to $41 from $44, while maintaining an Overweight rating. However, there was a subsequent adjustment where Piper Sandler downgraded Peoples Bancorp to Neutral from Overweight, with a revised Price Target of $30 from $31.

As of February 23, 2024, these are the latest updates on Peoples Bancorp’s stock rating and price targets from Piper Sandler.

PEBO Stock Shows Positive Performance on February 23, 2024

On February 23, 2024, PEBO stock showed positive performance as it traded in the middle of its 52-week range and above its 200-day simple moving average. The price of PEBO shares increased by $0.22 since the market last closed, representing a 0.78% rise. The stock opened at $28.64, which was $0.29 higher than its previous close. Overall, PEBO stock had a strong start on February 23, 2024, with both price momentum and price change indicating positive performance. Investors may be optimistic about the company’s future prospects, leading to increased buying activity and driving the stock price higher. It is important for investors to continue monitoring PEBO stock performance and staying informed about any developments that may impact the stock price.

PEBO Stock Performance Analysis: Revenue and Net Income Increase, EPS Decrease

On February 23, 2024, PEBO stock showed mixed performances in terms of its financial indicators. According to data from CNN Money, the total revenue for PEBO was $526.82 million over the past year, which represented a 51.22% increase compared to the previous year. However, the total revenue for the last quarter was $149.38 million, which remained flat compared to the previous quarter.

The net income for PEBO was $112.56 million over the past year, reflecting an 11.62% increase compared to the previous year. The net income for the last quarter was $33.60 million, showing a 6.14% increase compared to the previous quarter.

In terms of earnings per share (EPS), PEBO reported $3.44 over the past year, which represented a 4.49% decrease compared to the previous year. The EPS for the last quarter was $0.96, which remained flat compared to the previous quarter.

Overall, while PEBO showed strong growth in total revenue and net income over the past year, there were some concerns regarding the decrease in EPS. Investors may want to closely monitor the company’s financial performance in the coming quarters to assess its long-term growth prospects.

Tags: PEBO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Analysts Bullish on Ardelyx NASDAQ ARDX with Positive Price Targets

Biotechnology Markets and money

The Power of Compounded Returns A Case Study of CRISPR Therapeutics

Alternative Energy Stock Market Today (1)

Kosmos Energy Prepares for Quarterly Earnings Report What to Expect

Recommended

CleanSpark Stock

CleanSpark Navigates Record Profits and Regulatory Challenges

6 months ago
European Lithium Stock

Setback for European Lithium as Austrian Court Orders Fresh Environmental Review

2 months ago
Celularity Stock

Celularity Shares Extend Losses Despite Financial Restructuring

4 months ago
Juniper Networks Stock

Juniper Networks Integration Marks New Era for HPE

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

National Healthcare’s Financial Report: A Crucial Test Approaches

XRP’s Dual Milestone: Regulatory Green Light Meets Core Protocol Upgrade

Coinbase Faces Mounting Pressure from Legal and Reputational Challenges

Terawulf Expands Infrastructure Portfolio with Major Site Acquisitions

Trending

NexPoint Residential Stock
Dividends

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

by Felix Baarz
February 4, 2026
0

Investors in NexPoint Residential Trust will receive a comprehensive update on the company's performance when it releases...

PC Connection Stock

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

February 4, 2026
Fossil Stock

Fossil Group Stock Surges Past Key Technical Threshold

February 4, 2026
NextGen Healthcare Stock

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

February 4, 2026
Arcus Biosciences Stock

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

February 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results
  • PC Connection Set to Report Full-Year and Fourth Quarter Earnings
  • Fossil Group Stock Surges Past Key Technical Threshold

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com